Assessment of outcomes of consolidation therapy by number of cycles of blinatumomab received in newly diagnosed measurable residual disease negative patients with B-lineage acute lymphoblastic leukemia: In the ECOG-ACRIN E1910 Randomized Phase III National Clinical Trials Network Trial Meeting Abstract
| Authors: | Luger, S. M.; Sun, Z.; Mattison, R. J.; Paietta, E.; Roberts, K. G.; Zhang, Y.; Racevckis, J.; Lazarus, H. M.; Rowe, J. M.; Arber, D. A.; Wieduwilt, M. J.; Liedtke, M.; Bergeron, J.; Wood, B. L.; Zhao, Y.; Wu, G.; Chang, T. C.; Zhang, W.; Pratz, K. W.; Dinner, S. N.; Frey, N. V.; Gore, S. D.; Bhatnagar, B.; Atallah, E. L.; Uy, G. L.; Jeyakumar, D.; Lin, T. L.; Willman, C. L.; DeAngelo, D. J.; Sharon, E.; Little, R. F.; Erba, H. P.; Stone, R. M.; Mullighan, C. G.; Litzow, M. R.; Tallman, M. S. |
| Abstract Title: | Assessment of outcomes of consolidation therapy by number of cycles of blinatumomab received in newly diagnosed measurable residual disease negative patients with B-lineage acute lymphoblastic leukemia: In the ECOG-ACRIN E1910 Randomized Phase III National Clinical Trials Network Trial |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 2877 |
| Language: | English |
| ACCESSION: | WOS:001159740301277 |
| DOI: | 10.1182/blood-2023-189648 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
